ST. CLOUD, Minn., Feb. 21 /PRNewswire/ -- Professionals in the pharmaceutical and biotechnology industries will get a first look at the latest innovation in bioreactors at InterPhex 2008, the annual pharmaceutical manufacturing conference and exhibition.
ATMI LifeSciences and DCI-Biolafitte will launch Nucleo, a new generation of single-use bioreactors, during the trade show at the Pennsylvania Convention Center in Philadelphia March 26-28. The new product will be on display at booths 231 and 1755.
Nucleo represents the state-of-the-art response to the evolution of biotech processes and is perfectly suited to laboratory environments, current methods of process development and flexible manufacturing. The Nucleo is a family of stirred bioreactor systems for batch, fed batch, or perfusion cell culture and is scalable from laboratory to industrial applications.
The Nucleo is intended to provide a complete turn-key solution to cell culturists as an alternative to stainless steel classical bioreactors, without need for extended validations. Other benefits include:
For more information about Nucleo, visit www.nucleo-bioreactor.com. To contact DCI-Biolafitte and ATMI LifeSciences North America, e-mail info@nucleo-bioreactor.com.
CONTACT: Brian Welborn of DCI-Biolafitte, +1-320-250-5331
Web site: http://www.nucleo-bioreactor.com/
